Assessment of Peripheral Neuropathy in Ankylosing Spondylitis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
investigators hypothesized that peripheral neuropathy in ankylosing spondylitis is associated with higher disease activity, greater central sensitization, worse functional impairment, and poorer quality of life.
Eligibility criteria
Qualifiers
Patients aged ≥18 years
Diagnosis of ankylosing spondylitis according to the modified New York criteria (6).
Ability to provide informed consent
Disqualifiers
Patients under the age of 18 years.
Patients with definite diagnosis for any other systemic autoimmune disorders.
Diabetes mellitus
Chronic renal or hepatic disease
Trial design
Treatments tested in this trial
- Nerve conduction study
Treatment groups
45 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov